1. Home
  2. VCEL vs BHVN Comparison

VCEL vs BHVN Comparison

Compare VCEL & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vericel Corporation

VCEL

Vericel Corporation

N/A

Current Price

$33.54

Market Cap

1.7B

Sector

Health Care

ML Signal

N/A

Logo Biohaven Ltd.

BHVN

Biohaven Ltd.

N/A

Current Price

$9.84

Market Cap

1.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VCEL
BHVN
Founded
1989
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.6B
IPO Year
1996
2022

Fundamental Metrics

Financial Performance
Metric
VCEL
BHVN
Price
$33.54
$9.84
Analyst Decision
Strong Buy
Buy
Analyst Count
5
14
Target Price
$58.50
$27.69
AVG Volume (30 Days)
423.1K
1.8M
Earning Date
05-18-2026
06-08-2026
Dividend Yield
N/A
N/A
EPS Growth
60.00
26.08
EPS
0.32
N/A
Revenue
$276,259,000.00
N/A
Revenue This Year
$19.09
N/A
Revenue Next Year
$17.96
N/A
P/E Ratio
$105.00
N/A
Revenue Growth
16.45
N/A
52 Week Low
$29.24
$7.48
52 Week High
$49.10
$31.18

Technical Indicators

Market Signals
Indicator
VCEL
BHVN
Relative Strength Index (RSI) 37.24 35.65
Support Level $29.59 $9.32
Resistance Level $38.48 $10.28
Average True Range (ATR) 1.47 0.64
MACD -0.36 -0.18
Stochastic Oscillator 9.47 16.08

Price Performance

Historical Comparison
VCEL
BHVN

About VCEL Vericel Corporation

Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

Share on Social Networks: